At Delee, we aim to radically change the way cancer is detected, monitored and treated. Through the development of the CytoCatchâ˘, which is a highly sensitive automated benchtop device, we have made possible to rapidly isolate and efficiently analyze circulating tumor cells from blood samples. This innovative technology enables not only the early detection of cancer, but also the continuous monitoring of the diseaseâs evolution and the effectiveness of therapies that are being administered; increasing the patientâs chances of defeating cancer.
